Alpine Immune Sciences, Inc.
PD-L2 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
Last updated:
Abstract:
Provided herein are immunomodulatory proteins comprising variant PD-L2 and nucleic acids encoding such proteins. The immunomodulatory proteins provide therapeutic utility for a variety of immunological and oncological conditions. Compositions and methods for making and using such proteins are provided.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2018
Issue date:
6 May 2021